Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Francesca Toraldo"'
Autor:
Nicoletta Mancianti, Andrea Guarnieri, Mariapia Lenoci, Francesca Toraldo, Domenica Paola Salvo, Massimo Belluardo, Ernesto Iadanza, Fabio Ferretti, Giuseppe Marotta, Guido Garosi
Publikováno v:
Clinical Kidney Journal. 16:996-1004
Background The main purpose of our study was to evaluate the ability of renal functional reserve (RFR) to stratify the risk of acute kidney injury (AKI) occurrence within 100 days of hematopoietic stem cell transplantation (HSCT) and to predict any f
Autor:
Nicoletta Mancianti, Andrea Guarnieri, Mariapia Lenoci, Francesca Toraldo, Domenica Paola Salvo, Massimo Belluardo, Giuseppe Marotta, Guido Garosi
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Haematopoietic stem cell transplantation (HSCT) is an effective treatment for myelo-lymphoproliferative disorders. Acute kidney injury (AKI) is a major complication of HSCT (incidence ≈15%–60%), usually occurs in the first 100
Autor:
Gabriella Jacomelli, Antonio Federico, Francesca Toraldo, Mauro Mondelli, Vanna Micheli, Maria Alessandra Carluccio, Monica Tozzi, Alessandro Bucalossi, Mariapia Lenoci, Francesco Sicurelli, M. T. Dotti, Giuseppe Marotta, Elena Cardaioli
Publikováno v:
Journal of Neurology. 259:1985-1987
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an inherited and almost invariably fatal disorder due to thymidine phosphorylase (TP) deficiency leading to a general increase in its substrates, deoxythymidine (dThd) and deoxyuridine
Autor:
Rosaria Crupi, Lara Aprile, Marzia Defina, Domenico Russo, Cristina Papayannidis, Nicoletta Testoni, Giuseppe Marotta, Francesco Lauria, Alessandro Gozzetti, Stefania Paolini, Pier Paolo Piccaluga, Monica Tozzi, Michele Malagola, Monica Bocchia, Giovanni Martinelli, Francesca Toraldo, Michela Rondoni, Michele Baccarani
Abstract 4147 Background Standard induction chemotherapy for Acute Myeloid Leukaemia (AML) is represented by a combination of cytarabine and antracyclin with or without the addition of a third drug (e.g. etoposide), with a Complete Remission (CR) rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfed24fb3ac1d8e47269cdc11e4d3660
http://hdl.handle.net/11379/31056
http://hdl.handle.net/11379/31056
Autor:
Francesco Forconi, Elisa Sozzi, Donatella Raspadori, Francesca Toraldo, Teresa Amato, Francesco Lauria
Hairy cell leukemia (HCL) is a rare B-cell neoplasm associated with a good outcome after treatment with single-agent purine-analogs (PAs) Pentostatin or Cladribine [1]. However, responses are not u...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::324ccb82e87c39a4246b401c0716f7cb
http://hdl.handle.net/11365/25563
http://hdl.handle.net/11365/25563
Autor:
Tamara Intermesoli, Francesco Forconi, Pietro Maria Stefani, Luigi Rigacci, Francesco Zaja, Caterina Stelitano, Francesca Toraldo, Alfonso Zaccaria, Piero Galieni, Donatella Raspadori, Andrea Gallamini, Monica Bocchia, Marzia Defina, Francesco Lauria, Elisa Sozzi, Mariapia Lenoci
Hairy cell leukemia (HCL) is a rare B-cell neoplasm highly responsive to purine analogues 2Chlorodeossiadenosine (2CdA) or Desossicoformicin or Interferons as single agents, and only a minority are refractory. Patients who obtain any response (either
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b65f1c24f02b3d379e63ca7b3809cc9
http://hdl.handle.net/11365/999370
http://hdl.handle.net/11365/999370
Autor:
Daniela Marconi, Valter Gattei, Emanuele Zucca, Francesco Forconi, Elisa Sozzi, Clara Deambrogi, Francesco Bertoni, Gianluca Gaidano, Ivo Kwee, Davide Rossi, Francesco Lauria, Andrea Rinaldi, Francesca Toraldo, Riccardo Bomben
Publikováno v:
Blood. 110:4696-4696
Chronic lymphocytic leukemia (CLL) with deletion of 17p(p53) locus (17p- CLL) identifies the most aggressive CLL subset, due to active disease course and resistance to current treatments. Intrinsic mechanisms of the poor prognosis of 17p- CLL are sca
Autor:
Alessandro Gozzetti, Francesca Toraldo, Mariapia Lenoci, Donatella Raspadori, Elisa Sozzi, Francesco Forconi, Alberto Fabbri, Maristella Tassi, Francesco Lauria
Publikováno v:
Blood. 110:2055-2055
The intravenous regimen of fludarabine plus cyclophosphamide (FC) at conventional doses is highly effective in Chronic lymphocytic leukemia (CLL), where it is currently indicated in first line therapy, and low-grade non Hodgkin lymphomas (LG-NHL). We
Autor:
Francesca Toraldo, Monica Tozzi, Giuseppe Marotta, Alessandra Renieri, Alessandro Bucalossi, Mariapia Lenoci, Cinzia Castagnini, Rosangela Artuso
Publikováno v:
Biology of Blood and Marrow Transplantation. (12):1749-1750